+49 30 9210765-50


For decades microorganisms have been applied for the production of pharmacologically relevant drugs. We use the ORGANOBALANCE microbial strain collection of "probiotic" microorganisms for the development of new products that are highly specific but gentle in their action. They are patent protected and ready for registration as medical devices or pharmaceutical products.

We enable

  • new therapeutic and prophylactic approaches for hitherto inadequately treatable indications
  • alternatives to conventional therapies based on highly-active ingredients isolated from selected lactobacilli and yeast strains
  • the development of products for gastro-intestinal disorders and skin and mucosal diseases

We offer

  • many years of proven expertise in the field of rational strain design constructing new yeast strains for the production of therapeutic and diagnostic proteins.

Please contact us for more information: info@organobalance.com


Novozymes Berlin GmbH

  • Gustav-Meyer-Allee 25, Geb.12, Etage 3
  • 13355 Berlin
  • Germany
  • info@organobalance.com
  • Tel.: +49 30 9210765-50
  • Fax: +49 30 9210765-60
  • www.organobalance.de